Market Closed

PBYI
Puma Biotechnology
$ 7.77
-3.84%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Puma Biotechnology News

Latest Puma Biotechnology Stock News & PBYI Headlines

Puma: 3 Key Takeaways for Long-Term Investors
7 days ago | fool.com
Puma Biotechnology, Inc. (PBYI) Q3 2026 Earnings Call Prepared Remarks Transcript
8 days ago | seekingalpha.com
Puma Biotechnology Q3 Earnings Call Highlights
9 days ago | marketbeat.com
Puma Biotechnology Reports Third Quarter 2026 Financial Results
9 days ago | businesswire.com
Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial Results
23 days ago | businesswire.com
Will Nerlynx Continue to Aid Puma Biotechnology's Top Line in Q3?
a month ago | zacks.com
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
2 months ago | zacks.com
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
2 months ago | businesswire.com
Is Puma Biotechnology (PBYI) a Great Value Stock Right Now?
3 months ago | zacks.com
PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised
3 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

PBYI
Puma Biotechnology
$ 7.77
-3.84%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago